Andrew Quick - 18 May 2021 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role: Chief Technology Officer
Signature: /s/ Donna Shiroma, by power of attorney
Issuer symbol: RCEL
Transactions as of: 18 May 2021
Transactions value $: $0
Form type: 4
Filing time: 07 Sep 2021, 16:05:27 UTC
Next filing: 06 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCEL	Common Stock	Award		+10.5K			10.5K	06 Jul 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCEL	Stock Options (Right to Buy)	Award	$0	+4.04K	+25%	$0.00	20.2K	18 May 2021	Common Stock	4.04K	$6.32	Direct	F2
transaction	RCEL	Stock Options (Right to Buy)	Award	$0	+6.93K		$0.00	6.93K	06 Jul 2021	Common Stock	6.93K	$20.21	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units.
F2	These Stock Options were originally granted on May 18, 2017 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition.
F3	These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.